Literature DB >> 1987646

The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome.

C Simard1, P Jolicoeur.   

Abstract

The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with anti-neoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987646     DOI: 10.1126/science.1987646

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

1.  In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.

Authors:  D M Neville; J Scharff; K Srinivasachar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 2.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus.

Authors:  C Simard; S J Klein; T Mak; P Jolicoeur
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 4.  Curing HIV: lessons from cancer therapy.

Authors:  Ronald Mitsuyasu
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

5.  Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs.

Authors:  C Simard; M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage.

Authors:  M Huang; C Simard; D G Kay; P Jolicoeur
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells.

Authors:  M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus.

Authors:  Y Kubo; Y Nakagawa; K Kakimi; H Matsui; M Iwashiro; K Kuribayashi; T Masuda; H Hiai; T Hirama; S Yanagawa
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis.

Authors:  G T Cole; K Saha; K R Seshan; K T Lynn; M Franco; P K Wong
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus.

Authors:  C Gravel; D G Kay; P Jolicoeur
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.